Stevens Capital Management LP grew its stake in Centene Co. (NYSE:CNC – Free Report) by 66.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,473 shares of the company’s stock after acquiring an additional 3,776 shares during the quarter. Stevens Capital Management LP’s holdings in Centene were worth $574,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of CNC. Capital Advisors Ltd. LLC increased its stake in Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after purchasing an additional 177 shares in the last quarter. Rialto Wealth Management LLC bought a new stake in Centene during the 4th quarter worth approximately $30,000. OFI Invest Asset Management bought a new stake in Centene during the 4th quarter worth approximately $33,000. SRS Capital Advisors Inc. increased its stake in Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after purchasing an additional 267 shares in the last quarter. Finally, Riverview Trust Co increased its stake in Centene by 172.7% during the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after purchasing an additional 480 shares in the last quarter. 93.63% of the stock is owned by institutional investors.
Centene Stock Performance
Shares of CNC stock opened at $58.88 on Monday. The business’s 50-day moving average price is $60.27 and its 200-day moving average price is $63.08. Centene Co. has a 12 month low of $55.03 and a 12 month high of $80.59. The firm has a market capitalization of $29.21 billion, a price-to-earnings ratio of 9.44, a PEG ratio of 0.80 and a beta of 0.40. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 0.70.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. Truist Financial lowered their target price on Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research note on Friday, December 13th. Wells Fargo & Company reduced their price target on Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research report on Friday, February 14th. Argus downgraded Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. JPMorgan Chase & Co. reaffirmed an “overweight” rating and set a $75.00 price target (down previously from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price target on shares of Centene in a research report on Wednesday, December 11th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $79.92.
Read Our Latest Stock Analysis on CNC
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
See Also
- Five stocks we like better than Centene
- 5 discounted opportunities for dividend growth investors
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 ETFs to Ride the VIX Surge During Market Volatility
- Pros And Cons Of Monthly Dividend Stocks
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.